Results of this phase III trial could change the current standard of care for treating nonseminomatous or combined germ cell tumors of the testis.
Investigators report on long-term results of sentinel node (SN) approach in patients with clinical stage I testicular tumors.
Although rare, is breast cancer in males genetic? Researchers provide details.
A 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Researchers identified two germline pathogenic variants in CHEK2 that may account for a minority of men diagnosed with testicular germ cell tumors.
A registry study suggests that there may be a familial association between ovarian and testicular cancers.
Fewer patients diagnosed with testicular cancer were uninsured, and fewer were diagnosed with late-stage disease, following the Affordable Care Act’s Medicaid enrollment expansion.
Researchers have discovered that testicular cancer’s responsiveness to conventional chemotherapy is likely determined during prenatal development.
Researchers found that combining palonosetron, aprepitant, and dexamethasone represents an effective and well-tolerated treatment to prevent CINV in testicular cancer patients receiving cisplatin.
A post-hoc analysis found that brain metastases are more frequent in patients with advanced germ cell tumors who have received dose-dense chemotherapy compared with those administered the BEP regimen.